Clinical experience with combination disease-modifying antirheumatic drug therapy with cyclosporine

Clinical and Experimental Rheumatology

Volumn 17, Issue 6 SUPPL. 18, 1999, Pages

  Johns, K ^a   Littlejohn, G ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b Rheumatology Department   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

Combination therapy; Cyclosporine; DMARD's; Life table analysis; Methotrexate; Rheumatoid arthritis treatment; Side effects

Indexed keywords

ANTIRHEUMATIC AGENT; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; LIFE TABLE; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0032694608     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. PINCUS T, STEIN CM: Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: Some explanations and suggestions for future studies. Clin Exp Rheumatol 1997; 15 (Suppl.17): S27-S38.
2. BOERS M, VERHOEVEN AC, MARKUSSE H et al.: Randomised comparison of combined stepdown prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18.
3. AXTENS RSK, MORAND EF, LITTLEJOHN GO: Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis - Tolerance of therapy (letter). Ann Rheum Dis 1994; 53: 703.
4. MORAND EF, MCCLOUD PI, LITTLEJOHN GO: Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 1992; 51: 1318-21.
5. MORAND EF, MCCLOUD PI, LITTLEJOHN GO: Life table analysis of 879 treatment episodes with slow-acting antirheumatic drugs in community rheumatology practice. J Rheumatol 1992; 19: 704-8.
6. BUCHBINDER R, HALL S, SAMBROOK PN et al.: Methotrexate therapy in rheumatoid arthritis: A life table review of 587 patients treated in community practice. J Rheumatol 1993; 20: 639-44.
7. WLUKA A, BUCHBINDER R, MYLVAGANAM A et al.: Long term methotrexate use in rheumatoid arthritis: 12-year follow-up of 460 patients. ANZJM 1998; 28: Suppl. 740.
8. JOHNS KR, LITTLEJOHN GO: The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis. J Rheumatol 1999 (in press).
9. DOUGADOS M, AWADA H, AMOR B: Cyclosporin in rheumatoid arthritis; A double blind placebo controlled study in 52 patients. Ann Rheum Dis 1988; 47: 127-33.
10. TUGWELL, BOMBARDIER C, GENT M et al: Low dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051-5.
11. STEIN CM, PINCUS T, YOCUM D et al: Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. An open label extension study. Arthritis Rheum 1997; 40: 1843-51.
12. GONZALEZ-GAY MA, BLANCO R, GARCIA-PORRUA C et al.: Long term follow-up of patients receiving combined therapy with cyclosporine and methotrexate (letter). Arthritis Rheum 1998; 41: 1703-4.